Mehta Rajendra H, Eagle Kim A, Coombs Laura P, Peterson Eric D, Edwards Fred H, Pagani Francis D, Deeb G Michael, Bolling Steven F, Prager Richard L
Division of Cardiology, University of Michigan, Ann Arbor 48105, USA.
Ann Thorac Surg. 2002 Nov;74(5):1459-67. doi: 10.1016/s0003-4975(02)03928-0.
Although increasing age has been associated with greater risk of mortality for patients undergoing mitral valve replacement, it is less clear whether this elevated risk is related to age-related differences in comorbidity or other clinical characteristics.
A population of 31,688 patients from The Society of Thoracic Surgeons National Cardiac Database undergoing mitral valve replacement either alone or in combination with coronary artery bypass grafting or tricuspid surgical procedures from 1997 to 2000 was examined to assess age-related variation in clinical features, morbidity, and mortality. Multivariable logistic regression was used to determine the effect of age after adjusting for other known risk factors. A classification tree was used to identify low-risk elderly (> or = 75 years) patients.
Operative mortality increased four-fold from 4.1% in patients aged less than 50 years up to 17.0% in patients aged 80 years or more. Similarly, major operative complications (stroke, prolonged ventilation, reoperation for bleeding, renal failure, and sternal infection) also increased with age, rising from 13.5% (age < 50 years) to 35.5% (age > or = 80 years). Multivariable adjustment attenuated the odds of operative mortality, but age remained a significant risk factor. After adjusting for other patient risk factors, age accounted for 13% and 10% of the explainable risk for mortality and morbidity, respectively. Among the elderly, four variables (hemodynamic instability, New York Heart Association class IV, renal failure, and concomitant coronary artery bypass grafting) were identified to distinguish levels of risk, from operative mortality rates exceeding 31% to those with 7.7% mortality.
Operative mortality and morbidity rise with increasing age of patients undergoing mitral valve replacement. Although this excess risk is partially a result of increased comorbid burden and other operative factors, age remains an independent powerful risk factor for operative risk for mitral valve replacement. Understanding the relationship of age with other risk factors for mitral valve replacement can help stratify risk, enabling physicians to identify lower risk patients.
尽管年龄增长与二尖瓣置换术患者的死亡风险增加相关,但这种风险升高是否与合并症或其他临床特征的年龄相关差异有关尚不清楚。
对1997年至2000年来自胸外科医师协会国家心脏数据库的31688例接受二尖瓣置换术(单独或联合冠状动脉旁路移植术或三尖瓣手术)的患者进行研究,以评估临床特征、发病率和死亡率的年龄相关差异。多变量逻辑回归用于在调整其他已知风险因素后确定年龄的影响。使用分类树来识别低风险老年(≥75岁)患者。
手术死亡率从年龄小于50岁患者的4.1%增加了四倍,至80岁及以上患者的17.0%。同样,主要手术并发症(中风、通气时间延长、因出血再次手术、肾衰竭和胸骨感染)也随年龄增加,从13.5%(年龄<50岁)升至35.5%(年龄≥80岁)。多变量调整降低了手术死亡的几率,但年龄仍然是一个重要的风险因素。在调整其他患者风险因素后,年龄分别占死亡率和发病率可解释风险的13%和10%。在老年人中,确定了四个变量(血流动力学不稳定、纽约心脏协会IV级、肾衰竭和同期冠状动脉旁路移植术)来区分风险水平,手术死亡率从超过31%到7.7%不等。
二尖瓣置换术患者的手术死亡率和发病率随年龄增加而上升。尽管这种额外风险部分是合并症负担增加和其他手术因素的结果,但年龄仍然是二尖瓣置换术手术风险的独立强大风险因素。了解年龄与二尖瓣置换术其他风险因素的关系有助于分层风险,使医生能够识别低风险患者。